Critical Determinants of Limb Ischemia**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 5, 2008, Pages 394-396

  Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ATHEROSCLEROSIS; CHROMOSOME 7; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EDITORIAL; ELECTRON TRANSPORT; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LOWER EXTREMITY; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; RECEPTOR, TIE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48949118097     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.004     Document Type: Editorial

References (17)

1. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Mefydicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 47 (2006) e1-e192
2. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
3. McDermott M.M., Greenland P., Liu K., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286 (2001) 1599-1606
4. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S (2007) S5-S67
5. Szuba A., Oka R.K., Harada R., and Cooke J.P. Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 11 (2006) 155-163
6. Brass E.P., Hiatt W.R., and Green S. Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion. Vasc Med 9 (2004) 293-301
7. Ubbink D.T., Spincemaille G.H., Reneman R.S., and Jacobs M.J. Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 30 (1999) 114-121
8. Findley C.M., Mitchell R.G., Duscha B.D., Annex B.H., and Kontos C.D. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 52 (2008) 387-393
9. Kowanetz M., and Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12 (2006) 5018-5022
10. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie2 in blood vessel formation. Nature (Lond) 376 (1995) 70-74
11. Semenza G.L. Hypoxia-inducible factor (HIF-1) pathway. Sci STKE 2007 (2007) cm8
12. Findley C.M., Cudmore M.J., Ahmed A., and Kontos C.D. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27 (2007) 2619-2626
13. Siemeister G., Schirner M., Weindel K., et al. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res 59 (1999) 3185-3191
14. Becker C.M., Farnebo F.A., Iordanescu I., et al. Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1. Cancer Biol Ther 1 (2002) 548-553
15. Riely G.J., and Miller V.A. Vascular endothelial growth factor trap in non small cell lung cancer. Clin Cancer Res 13 (2007) s4623-s4627
16. Resar JR, Roguin A, Voner J, et al. Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest;128:787-91.
17. Dokun A.O., Keum S., Hazarika S., et al. A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia. Circulation 117 (2008) 1207-1215